Cowealth Medical Holding Co Ltd (4745) — Cash Flow Reinvestment Rate

Latest as of June 2025: 0.24x

Cowealth Medical Holding Co Ltd (4745) has a Cash Flow Reinvestment Rate of 0.24x as of June 2025, reinvesting NT$119.90 Million (capex NT$5.45 Million plus investments NT$-114.45 Million) from operating cash flow of NT$508.13 Million. Check cash flow quality index of Cowealth Medical Holding Co Ltd to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.24x
(Capex + Investments) / Operating CF

Total Reinvested

NT$119.90 Million
Capex + Investments

Operating Cash Flow

NT$508.13 Million
TWD

Capital Expenditures

NT$5.45 Million
TWD

Cowealth Medical Holding Co Ltd Cash Flow Reinvestment Rate (2017–2025)

Historical reinvestment intensity for Cowealth Medical Holding Co Ltd across 6 annual periods. Explore Cowealth Medical Holding Co Ltd (4745) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Cowealth Medical Holding Co Ltd (2017–2025)

Year-by-year capital reinvestment analysis for Cowealth Medical Holding Co Ltd. For live market cap and broader valuation context, see 4745 market cap overview.

Year Reinvestment Rate Total Reinvested (TWD) Operating CF Capex YoY Change
2025 36.65x NT$569.18 Million NT$15.53 Million NT$14.69 Million ▲ +20229.5%
2024 0.18x NT$84.63 Million NT$469.43 Million NT$62.35 Million ▼ -98.0%
2023 9.10x NT$409.77 Million NT$45.02 Million NT$236.50 Million ▲ +1717.2%
2020 0.50x NT$403.07 Million NT$804.75 Million NT$28.09 Million ▼ -26.7%
2018 0.68x NT$91.30 Million NT$133.64 Million NT$59.87 Million ▼ -53.2%
2017 1.46x NT$197.28 Million NT$135.26 Million NT$40.69 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow